Fritze D, Kaufmann M, Drings P, Fedra G
Oncology. 1978;35(6):242-5. doi: 10.1159/000225297.
Leukocyte adherence inhibition (LAI) tests for the assessment of tumor immunity in vitro have been based on the assumption that the adherence of the leukocytes is inhibited by specific interaction with an antigenic tumor extract. However, loss of leukocyte adherence could depend on several non-immunological factors including disease state of the leukocyte donor and the presence of a variety of agents, proteins or tissue extracts. We have studied LAI , therefore, using different species and concentrations of serum protein or tissue extracts. Our results show that leukocytes from patients with a variety of diseases adhere to glass in a rather consistent fashion. High concentrations of serum protein or tissue extract inhibited leukocyte adherence. 39 breast cancer patients and 38 female controls were studied with a total of 23 solubilized extracts from breast carcinoma, other tumor and non-tumor tissues. Breast cancer patients showed selective LAI in the presence of 200 microgram per test tube of several breast carcinoma extracts.
用于体外评估肿瘤免疫的白细胞黏附抑制(LAI)试验基于这样一种假设,即白细胞的黏附通过与抗原性肿瘤提取物的特异性相互作用而受到抑制。然而,白细胞黏附的丧失可能取决于多种非免疫因素,包括白细胞供体的疾病状态以及多种试剂、蛋白质或组织提取物的存在。因此,我们使用不同种类和浓度的血清蛋白或组织提取物研究了LAI。我们的结果表明,患有多种疾病的患者的白细胞以相当一致的方式黏附于玻璃。高浓度的血清蛋白或组织提取物抑制白细胞黏附。我们对39名乳腺癌患者和38名女性对照进行了研究,共使用了来自乳腺癌、其他肿瘤和非肿瘤组织的23种可溶解提取物。在每试管200微克的几种乳腺癌提取物存在的情况下,乳腺癌患者表现出选择性LAI。